Unveiling the Potential Risks: Long-Term Health Effects of Chronic Exposure to Bisphenol A
DOI:
https://doi.org/10.61173/5xd5rv23Keywords:
Pharmaceutical personal care products, Bi-sphenol A, Endocrine disrupter, Human healthAbstract
The effects of bisphenol A (BPA) on estrogen levels, fertility, obesity, and liver injury were investigated. Through a series of control results (CR1 to CR16), this study examined the multiple effects of BPA on biological processes. The findings show that when exposed to BPA, estrogen levels rise, fertility decreases, obesity increases through changes in liver weight, and damage can be observed through confocal imaging. These results varied in different settings, suggesting partial or full support for the original hypothesis that BPA has various effects on estrogen, fertility, obesity, and liver damage. It is worth noting that in some cases, such as CR5, estrogen levels are not affected by BPA, but fertility, obesity, and injury are. In contrast, CR16 significantly refuted this hypothesis, suggesting that BPA may not have a substantial effect on estrogen, fertility, obesity, or impairment in specific situations. Overall, the study highlights the complex relationship between BPA exposure and biological systems, underscoring the need for further research to fully understand the effects of this compound on estrogen regulation, fertility, obesity development, and liver health. These findings provide valuable insights into the complex interactions between BPA and human physiology.
References
Chen, Y., Chen, X., Bao, W., Liu, G., Wei, W., & Ping, Y. (2024). An oncolytic virus–T cell chimera for cancer immunotherapy. Nature Biotechnology, 1-12. https://doi.org/10.1038/s41587- 023-02118-7 Chockley, P. J., Krenciute, G., Talbot, L. J., & Gottschalk, S. (2023). Synapse-tuned CARs enhance immune cell anti-tumor
Dean&Francis Qi Yan, Zihan Mo, Xiaxi Tian, Xinjun Wen activity. Nature Biotechnology, 41(10), 1434-1445. https://doi. org/10.1038/s41587-022-01650-2 Evgin, L., Kottke, T., Tonne, J., Thompson, J., Huff, A. L., Moore, M., Michael, J., Driscoll, C., Pulido, J., Swanson, E., Kennedy, R., Coffey, M., Loghmani, H., Sanchez-Perez, L., Olivier, G., Harrington, K., Pandha, H., Melcher, A., Diaz, R. M., . . . Vile, R. G. (2022). Oncolytic virus–mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice. Science Translational Medicine. https://doi.org/abn2231 Gu, K., De Velde, R. V., Pitz, M., & Silver, S. (2020). Recurrent melanoma development in a Caucasian female with CDKN2A+ mutation and FAMMM syndrome: A case report. SAGE Open Medical Case Reports. https://doi. org/10.1177/2050313X20936034 Huang, J., Chan, S. C., Ko, S., Lok, V., Zhang, L., Lin, X., Lucero-Prisno Iii, D. E., Xu, W., Zheng, Z. J., Elcarte, E., Withers, M., & Wong, M. C. S. (2023). Global Incidence, Mortality, Risk Factors and Trends of Melanoma: A Systematic Analysis of Registries. American journal of clinical dermatology, 24(6), 965–975. https://doi.org/10.1007/s40257- 023-00795-3 Liu, Z. F., Chew, C. Y., Honavar, S., Maxwell, A., Sylivris, A., & Sheridan, A. (2024). Seeing beyond skin deep: High-resolution ultrasound in dermatology-A comprehensive review and future prospects. Journal of the European Academy of Dermatology and Venereology : JEADV, 38(7), 1305–1313. https://doi. org/10.1111/jdv.19939 Melanoma Treatment (PDQ®). (2024, April 16). Cancer.gov. https://www.cancer.gov/types/skin/hp/melanoma-treatmentpdq#_851 Robinson, C., Xu, M. M., Nair, S. K., Beasley, G. M., & Rhodin, K. E. (2022). Oncolytic viruses in melanoma. Frontiers in bioscience (Landmark edition), 27(2), 63. https://doi. org/10.31083/j.fbl2702063 Saginala, K., Barsouk, A., Aluru, J. S., Rawla, P., & Barsouk, A. (2021). Epidemiology of Melanoma. Medical sciences (Basel, Switzerland), 9(4), 63. https://doi.org/10.3390/medsci9040063
Downloads
Published
Issue
Section
License
Copyright (c) 2025 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
